We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Comprehensive Marketing Agreement Signed for Virtual Colonoscopy System

By MedImaging International staff writers
Posted on 17 Dec 2008
Visage Imaging, Inc. (Carlsbad, CA, USA), a wholly owned subsidiary of Mercury Computer Systems, Inc., has signed a comprehensive marketing agreement with Viatronix, Inc. (Stony Brook, NY, USA), a developer of two-dimensional (2D)/3D medical imaging and diagnostic software.

Under the agreement, Visage Imaging will act as a representative for Viatronix's V3D-Colon virtual colonoscopy product in the United States. The agreement expands Viatronix's domestic marketing arm, while extending Visage Imaging's applications portfolio for advanced visualization products.

"We are extremely excited to be working with Viatronix,” said Jim Schumacher, vice president and chief operating officer of Visage Imaging. ”Virtual colonoscopy is becoming a requirement within our customer base and the planned seamless integration of V3D-Colon with our Visage CS platform is the solution. We are proud to team up with a true market leader in providing this critical technology.”

"We are delighted to enter into this agreement, and believe the integrated solution harnesses the power of both products to deliver maximum benefit to the end user,” said Zaffar Hayat, CEO and president of Viatronix. "The timing could not be better because the demand for virtual colonoscopy is growing rapidly in the U.S.”

Related Links:
Visage Imaging
Viatronix

Ultrasonic Pocket Doppler
SD1
Mammography System (Analog)
MAM VENUS
Portable X-ray Unit
AJEX140H
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.